Kramer Levin Closes $292 Million Life Sciences and Technology Securitization Transaction
Kramer Levin represented the initial purchasers in connection with a $292 million securitization of life sciences and technology loans. The transaction closed on September 3, 2020.
We use cookies on this website to optimize user experience and site functionality and to give you the best possible experience. We do so with your approval. The choice is up to you. Learn more.